KLF5 |
CGR8 (embryonic stem cells) |
KLF5 overexpression |
Permissive
Robust
|
Mus musculus |
GSE49848
...
|
MA0599.1
|
KLF5 |
C2C12 (myoblasts) |
day0 of differentiation |
Permissive
Robust
|
Mus musculus |
GSE80812
...
|
MA0599.1
|
KLF5 |
C2C12 (myoblasts) |
day2 of differentiation |
Permissive
Robust
|
Mus musculus |
GSE80812
...
|
MA0599.1
|
KLF5 |
C2C12 (myoblasts) |
day5 of differentiation |
Permissive
Robust
|
Mus musculus |
GSE80812
...
|
MA0599.1
|
KLF5 |
BICR31 (Tongue squamous cell carcinoma cell) |
Treatment: untreated Tumor: Head and neck squamous cell carcinomas |
Permissive
Robust
|
Homo sapiens |
GSE88976
...
|
MA0599.1
|
KLF5 |
HEK293T (embryonic kidney) |
Treatment: Over-expressing KLF5 D418N |
Permissive
|
Homo sapiens |
GSE88976
...
|
MA0599.1
|
KLF5 |
HEK293T (embryonic kidney) |
treatment: Over-expressing KLF5 D418N |
Permissive
|
Homo sapiens |
GSE88976
...
|
MA0599.1
|
KLF5 |
HEK293T (embryonic kidney) |
Treatment: over-expressing KLF5 E419K |
Permissive
|
Homo sapiens |
GSE88976
...
|
MA0599.1
|
KLF5 |
HEK293T (embryonic kidney) |
Treatment: Over-expressing KLF5 E419K |
Permissive
|
Homo sapiens |
GSE88976
...
|
MA0599.1
|
KLF5 |
HEK293T (embryonic kidney) |
Treatment: Over-expressing KLF5 E419Q |
Permissive
Robust
|
Homo sapiens |
GSE88976
...
|
MA0599.1
|
KLF5 |
HEK293T (embryonic kidney) |
Treatment: Over-expressing KLF5 E419Q |
Permissive
Robust
|
Homo sapiens |
GSE88976
...
|
MA0599.1
|
KLF5 |
HEK293T (embryonic kidney) |
Treatment: Over-expressing KLF5 WT |
Permissive
Robust
|
Homo sapiens |
GSE88976
...
|
MA0599.1
|
KLF5 |
HEK293T (embryonic kidney) |
Treatment: Over-expressing KLF5 WT |
Permissive
Robust
|
Homo sapiens |
GSE88976
...
|
MA0599.1
|
KLF5 |
HCC95 (squamous cell lung carcinoma) |
Treatment: Over-expressing KLF5 D418N |
Permissive
Robust
|
Homo sapiens |
GSE88976
...
|
MA0599.1
|
KLF5 |
HCC95 (squamous cell lung carcinoma) |
Treatment: Over-expressing KLF5 WT |
Permissive
Robust
|
Homo sapiens |
GSE88976
...
|
MA0599.1
|
KLF5 |
HCC95 (squamous cell lung carcinoma) |
Treatment: Over-expressing KLF5 WT |
Permissive
Robust
|
Homo sapiens |
GSE88976
...
|
MA0599.1
|
KLF5 |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
|
Homo sapiens |
ENCSR974OFJ
|
MA0599.1
|
KLF5 |
CGR8 (embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE49848
...
|
MA0599.1
|
KLF5 |
3T3-L1 (embryonic fibroblasts) |
|
Permissive
|
Mus musculus |
GSE56872
...
|
MA0599.1
|
KLF5 |
HUES64 (embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE61475
...
|
MA0599.1
|
KLF5 |
HUES64 (embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE61475
...
|
MA0599.1
|
KLF5 |
HUES64 (embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE61475
...
|
MA0599.1
|
KLF5 |
AGS (gastric adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE51705
|
MA0599.1
|
KLF5 |
KATOIII (signet ring cell gastric adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE51705
|
MA0599.1
|
KLF5 |
YCC3 (gastric adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE51705
|
MA0599.1
|
KLF5 |
|
|
Permissive
|
Homo sapiens |
GSE64557
|
MA0599.1
|
KLF5 |
GP5d (colon adenocarcinoma) |
SIRAD21 |
Permissive
|
Homo sapiens |
GSE51234
|
MA0599.1
|
KLF5 |
LoVo (colorectal adenocarcinoma) |
PHASEM |
Permissive
|
Homo sapiens |
GSE51290
|
MA0599.1
|
KLF5 |
LoVo (colorectal adenocarcinoma) |
PHASES |
Permissive
|
Homo sapiens |
GSE51290
|
MA0599.1
|
KLF5 |
GP5d (colon adenocarcinoma) |
|
Permissive
|
Homo sapiens |
GSE51234
|
MA0599.1
|